S 4370

  • New York Senate Bill
  • 2021 Regular Session
  • Introduced in Senate
  • Senate
  • Assembly
  • Governor

Preserves access to affordable drugs

Abstract

Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

Bill Sponsors (13)

Votes


Actions


Jun 03, 2022

Senate

COMMITTED TO RULES

May 17, 2022

Senate

ADVANCED TO THIRD READING

May 16, 2022

Senate

2ND REPORT CAL.

May 11, 2022

Senate

1ST REPORT CAL.1331

May 05, 2022

Senate

PRINT NUMBER 4370B

Senate

AMEND AND RECOMMIT TO HEALTH

May 02, 2022

Senate

PRINT NUMBER 4370A

Senate

AMEND AND RECOMMIT TO HEALTH

Jan 05, 2022

Senate

REFERRED TO HEALTH

Feb 03, 2021

Senate

REFERRED TO HEALTH

Bill Text

Bill Text Versions Format
S4370 PDF HTML
S4370A PDF
S4370B PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.